Epidemiology of myelodysplastic syndromes

American Journal of Medicine

Volumn 125, Issue 7 SUPPL., 2012, Pages S2-

  Ma, Xiaomei ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

Incidence; Myelodysplastic syndromes; Prevalence; Prognosis

Indexed keywords

ANTHRACYCLINE;

ACUTE GRANULOCYTIC LEUKEMIA; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER RISK; CARDIOTOXICITY; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COMORBIDITY; CONGESTIVE HEART FAILURE; FANCONI ANEMIA; HUMAN; ICD-9; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; IONIZING RADIATION; MALIGNANT TRANSFORMATION; MYELODYSPLASTIC SYNDROME; OCCUPATIONAL EXPOSURE; OUTPATIENT DEPARTMENT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; UNITED STATES; WINE;

EID: 84862840164     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.04.014     Document Type: Article

References (31)

1. A. Fritz, C. Percy, A. Jack, S. Shanmugarathan, L. Sobin, D.M. Parkin, S. Whelan International Classification of Diseases for Oncology (ICD-O) 3rd ed. 2000 World Health Organization Geneva
2. H.R. Schumacher, S. Nand Myelodysplastic Syndromes: Approach to Diagnosis and Treatment New York: Igaku-Shoin Medical Publishers 1995
3. X. Ma, M. Does, A. Raza, S.T. Mayne Myelodysplastic syndromes: incidence and survival in the United States Cancer 109 2007 1536 1542
4. D.E. Rollison, N. Howlader, M.T. Smith Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs Blood 112 2008 45 52
5. S.L. Goldberg, E. Chen, M. Corral Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries J Clin Oncol 28 2010 2847 2852
6. X. Ma, R. Wang Ascertainment of patients with myelodysplastic syndromes J Clin Oncol 29 2011 e16
7. C.R. Cogle, B.M. Craig, D.E. Rollison, A.F. List Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries Blood 117 2011 7121 7125
8. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 17 Registries Research Data + Hurricane Katrina Impacted Louisiana Cases, National Cancer Institute, Division of Cancer Control & Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission.
9. M.A. Sekeres The epidemiology of myelodysplastic syndromes Hematol Oncol Clin North Am 24 2010 287 294
10. J.M. Guralnik, R.S. Eisenstaedt, L. Ferrucci, H.G. Klein, R.C. Woodman Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia Blood 104 2004 2263 2268
11. E.D. Warlick Epidemiology of myelodysplastic syndromes: many questions remain Leuk Lymphoma 52 2011 163 164
12. B. Deschler, M. Lübbert Acute myeloid leukemia: epidemiology and etiology Cancer 107 2006 2099 2107
13. S.S. Strom, V. Vélez-Bravo, E.H. Estey Epidemiology of myelodysplastic syndromes Semin Hematol 45 2008 8 13
14. A. Tefferi, J.W. Vardiman Myelodysplastic syndromes N Engl J Med 361 2009 1872 1885
15. D.J. Paustenbach, R.D. Bass, P. Price Benzene toxicity and risk assessment, 1972-1992: implications for future regulation Environ Health Perspect 101 suppl 6 1993 177 200
16. J. Björk, M. Albin, N. Mauritzson, U. Strömberg, B. Johansson, L. Hagmar Smoking and myelodysplastic syndromes Epidemiology 11 2000 285 291
17. C. Nisse, J.M. Haguenoer, B. Grandbastien Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France Br J Haematol 112 2001 927 935
18. S.S. Strom, Y. Gu, S.K. Gruschkus, S.A. Pierce, E.H. Estey Risk factors of myelodysplastic syndromes: a case-control study Leukemia 19 2005 1912 1918
19. R.R. West, D.A. Stafford, A. Farrow, A. Jacobs Occupational and environmental exposures and myelodysplasia: a case-control study Leuk Res 19 1995 127 139
20. G.M. Rigolin, A. Cuneo, M.G. Roberti Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings Br J Haematol 103 1998 189 197
21. M. Dalamaga, E. Petridou, F.E. Cook, D. Trichopoulos Risk factors for myelodysplastic syndromes: a case-control study in Greece Cancer Causes Control 13 2002 603 608
22. K.B. Miller Myelodysplastic syndromes P.H. Wiernik, J.M. Goldman, J.P. Dutcher, R.A. Kyle, Neoplastic Diseases of the Blood 4th ed. 2003 Cambridge University Press, Cambridge 395 414
23. X. Ma, U. Lim, Y. Park Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort Am J Epidemiol 169 2009 1492 1499
24. M. Ido, C. Nagata, N. Kawakami A case-control study of myelodysplastic syndromes among Japanese men and women Leuk Res 20 1996 727 731
25. X. Ma, S. Selvin, A. Raza, K. Foti, S.T. Mayne Clustering in the incidence of myelodysplastic syndromes Leuk Res 31 2007 1683 1686
26. J.M. Bennett The Myelodysplastic Syndromes: Pathobiology and Clinical Management: Basic and Clinical Oncology Vol. 27 2002 Marcel Dekker New York
27. P. Greenberg, C. Cox, M.M. LeBeau International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 1997 2079 2088
28. L. Malcovati, U. Germing, A. Kuendgen Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes J Clin Oncol 25 2007 3503 3510
29. R. Wang, C.P. Gross, S. Halene, X. Ma Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes Leuk Res 33 2009 1594 1598
30. R. Wang, C.P. Gross, S. Halene, X. Ma Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States Cancer Causes Control 20 2009 1369 1376
31. M. Extermann Measurement and impact of comorbidity in older cancer patients Crit Rev Oncol Hematol 35 2000 181 200